164 related articles for article (PubMed ID: 38486204)
21. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
[TBL] [Abstract][Full Text] [Related]
22. [Parameningeal or non-parameningeal head and neck rhabdomyosarcoma: a study based on propensity score matching and survival analysis].
Tao YJ; Zhen HN; Guan H; Shen J; Zhang FQ; Liu ZK
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 57(12):1409-1417. PubMed ID: 36707944
[No Abstract] [Full Text] [Related]
23. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135
[TBL] [Abstract][Full Text] [Related]
24. Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma.
Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):718-725. PubMed ID: 33516439
[TBL] [Abstract][Full Text] [Related]
25. The survival benefit of radiotherapy in localized primary adult rhabdomyosarcoma.
Zhao R; Yu X; Feng Y; Wang J; Chen Y; Mao Y; Yin W; Zhang Z; Guo X; Ma S
Asia Pac J Clin Oncol; 2020 Aug; 16(4):266-272. PubMed ID: 32285607
[TBL] [Abstract][Full Text] [Related]
26. Non-inferior efficacy of non-surgical treatment to surgical treatment in patients with nonmetastatic head and neck rhabdomyosarcoma: a SEER-based study.
Liang W; Li L; Wang M; Liu Y; Qiu Y; Zhang B; Wu Q; Wei Y
Clin Transl Oncol; 2023 Jun; 25(6):1779-1792. PubMed ID: 36640207
[TBL] [Abstract][Full Text] [Related]
27. Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution.
Frata P; Buglione M; Grisanti S; Bonetti B; Vitali E; De Stefani A; Magri E; Peveri A; Marini G; Rossi G; Magrini SM
Tumori; 2005; 91(6):456-62. PubMed ID: 16457141
[TBL] [Abstract][Full Text] [Related]
28. Complete second look operation and radiotherapy in locally advanced non-alveolar rhabdomyosarcoma in children: A report from the AIEOP soft tissue sarcoma committee.
Cecchetto G; Carretto E; Bisogno G; Dall'Igna P; Ferrari A; Scarzello G; Donfrancesco A; Alaggio R; Indolfi P; Carli M
Pediatr Blood Cancer; 2008 Nov; 51(5):593-7. PubMed ID: 18668515
[TBL] [Abstract][Full Text] [Related]
29. Patterns of failure after induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma: the Queen Mary Hospital experience.
Chua DT; Sham JS; Choy D; Kwong DL; Au GK; Kwong PW; Yau CC; Cheng AC; Wan KY
Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1219-28. PubMed ID: 11286826
[TBL] [Abstract][Full Text] [Related]
30. Long-term results in children with head and neck rhabdomyosarcoma: A report from the Italian Soft Tissue Sarcoma Committee.
Affinita MC; Ferrari A; Milano GM; Scarzello G; De Leonardis F; Coccoli L; Pericoli R; Basso E; Zanetti I; Scagnellato A; Bisogno G
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115716
[TBL] [Abstract][Full Text] [Related]
31. Therapy and prognostic significance of regional lymph node involvement in embryonal rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group.
Ben-Arush M; Minard-Colin V; Scarzello G; Fajardo RD; Terwisscha Van Scheltinga S; Bernier V; Jenney M; Gallego S; Zanetti I; Cesen M; Merks JHM; Bisogno G
Eur J Cancer; 2022 Sep; 172():119-129. PubMed ID: 35763871
[TBL] [Abstract][Full Text] [Related]
32. Head and neck rhabdomyosarcoma in adults.
Wu Y; Li C; Zhong Y; Guo W; Ren G
J Craniofac Surg; 2014 May; 25(3):922-5. PubMed ID: 24777012
[TBL] [Abstract][Full Text] [Related]
33. Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma.
Wolden SL; La TH; LaQuaglia MP; Meyers PA; Kraus DH; Wexler LH
Cancer; 2003 Jan; 97(1):179-85. PubMed ID: 12491519
[TBL] [Abstract][Full Text] [Related]
34. Patterns of Radiotherapy Use and Outcomes in Head and Neck Soft-Tissue Sarcoma in a National Cohort.
Kim JK; Verma N; McBride S; Riaz N; Boyle JO; Spielsinger D; Sabol C; Waldenberg T; Brinkman T; Alektiar K; Lee NY; Tsai CJ
Laryngoscope; 2020 Jan; 130(1):120-127. PubMed ID: 30892716
[TBL] [Abstract][Full Text] [Related]
35. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV.
Pappo AS; Meza JL; Donaldson SS; Wharam MD; Wiener ES; Qualman SJ; Maurer HM; Crist WM
J Clin Oncol; 2003 Feb; 21(4):638-45. PubMed ID: 12586800
[TBL] [Abstract][Full Text] [Related]
36. Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans-Atlantic, multicenter cross-sectional cohort study.
Hol MLF; Indelicato DJ; Slater O; Kolb F; Hewitt RJ; Ong J; Becking AG; Gains J; Bradley J; Sandler E; Gaze MN; Pieters B; Mandeville H; Fajardo RD; Schoot R; Merks JHM; Hammond P; Smeele LE; Suttie M
Pediatr Blood Cancer; 2023 Aug; 70(8):e30412. PubMed ID: 37249325
[TBL] [Abstract][Full Text] [Related]
37. Rhabdomyosarcoma of the head and neck region: experience at the pediatric unit of the Istituto Nazionale Tumori, Milan.
Meazza C; Ferrari A; Casanova M; Massimino M; Luksch R; Spreafico F; Cefalo G; Terenziani M; Polastri D; Podda M; Catania S; Cereda S; Gandola L; Fossati-Bellani F; Cantù G
J Otolaryngol; 2006 Feb; 35(1):53-9. PubMed ID: 16527019
[TBL] [Abstract][Full Text] [Related]
38. Worse Outcomes for Head and Neck Rhabdomyosarcoma Secondary to Reduced-Dose Cyclophosphamide.
Casey DL; Wexler LH; Wolden SL
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1151-1157. PubMed ID: 30508617
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes and prognosis of neuroendocrine neoplasms of the head and neck: a cohort from a single institution.
Shi X; Huang X; Wang K; Qu Y; Chen X; Wu R; Zhang Y; Zhang J; Luo J; Wang J; Yi J
J Cancer Res Clin Oncol; 2024 Jun; 150(6):288. PubMed ID: 38834932
[TBL] [Abstract][Full Text] [Related]
40. Head and neck squamous cell carcinoma of unknown primary: neck dissection and radiotherapy or definitive radiotherapy.
Demiroz C; Vainshtein JM; Koukourakis GV; Gutfeld O; Prince ME; Bradford CR; Wolf GT; McLean S; Worden FP; Chepeha DB; Schipper MJ; McHugh JB
Head Neck; 2014 Nov; 36(11):1589-1595. PubMed ID: 23996575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
